Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • Scientists issue call to arms over antifungal resistance
  • Policy / Pricing

Scientists issue call to arms over antifungal resistance

Pharmaphorum

Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.

Policy / PricingInfectious DiseaseRead full story

pharminent April 15, 2026

Pharmaphorum

Infectious disease experts from around the world are calling for concerted action to combat a “silent surge” in resistance to antifungal drugs.

Policy / PricingInfectious DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: S16 Ep52: Medical Crossfire: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application
Next: Whitepaper: CDMOs at a Crossroads

Related Stories

  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
  • Policy / Pricing

UK partners with Eli Lilly on obesity plan

pharminent June 29, 2026
  • Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.